ImmunoCellular Therapeutics Announces Initiation of Phase I Trial of...

ImmunoCellular Therapeutics, Ltd. today announced initiation of a phase I clinical trial of cancer vaccine ICT-121 as a potential treatment for patients with recurrent glioblastoma multiforme .

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130730005560&newsLang=en&ndmConfigId=1000639&vnsId=41